Treatment Options

Treatment Goals

The core goals of ADPKD treatment are: slow disease progression, control complications, protect kidney function, and maintain quality of life. Treatment plans are determined through shared decision-making between the patient and their nephrologist, taking into account disease stage, progression risk, and individual circumstances.

Medication Options

For objective information on each medication class — including mechanisms, monitoring requirements, nephrotoxicity warnings, and the evidence boundaries of traditional Chinese medicine — please refer to the Medication Index. This page provides an overview of the overall treatment framework only.

Tolvaptan (V2 Receptor Antagonist)

Tolvaptan is a vasopressin V2 receptor antagonist that slows the growth of total kidney volume (TKV) and the decline of eGFR. It is indicated for adult patients at high risk of rapid progression.

• What it does: Slows TKV growth and eGFR decline in patients with rapid progression risk.
• What it cannot do: It does not cure ADPKD or eliminate existing cysts.
• Monitoring: Liver function, serum sodium, and uric acid must be monitored regularly throughout treatment.
• Not suitable for: Patients with eGFR < 25 mL/min/1.73m², significant hepatic impairment, or during pregnancy.

ACEI / ARB (Blood Pressure Medication)

Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are first-line antihypertensive agents for ADPKD. They inhibit the renin-angiotensin system, controlling blood pressure while reducing proteinuria and protecting kidney function. They are commonly used in ADPKD patients with hypertension or proteinuria; suitability must be assessed by a physician.

• Risks: Hyperkalemia, transient creatinine elevation, dry cough (ACEI).
• Monitoring: Check creatinine and potassium 1–2 weeks after starting treatment or dose changes.

Lifestyle Management

• Blood pressure control — Target < 130/80 mmHg; follow a low-sodium diet.
• Adequate hydration — Maintain sufficient fluid intake unless your doctor restricts it.
• Moderate exercise — Stay active but avoid contact sports and activities with high risk of abdominal trauma, which may rupture cysts.
• Avoid nephrotoxic drugs — Use NSAID-class pain relievers with caution; consult your pharmacist or doctor.
• Regular monitoring — Follow your nephrologist's recommended schedule for kidney function checks.

Kidney Replacement Therapy

When eGFR falls below 15 mL/min/1.73m² or uremic symptoms appear, kidney replacement therapy becomes necessary:

• Hemodialysis — The most commonly used modality, typically performed at a dialysis center.
• Peritoneal dialysis — Can be performed at home, offering more flexibility.
• Kidney transplant — Generally offers the highest post-transplant quality of life; requires evaluation of donor compatibility and recipient fitness.